3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Pregnancy is the period from conception to birth. A pregnancy may be complicated by health problems or lifestyle issues known as risk factors. These risk factors can affect the mother or fetus, or both


Join our Mailing List



  << October >>  
S M T W T F S
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      




Monthly Archives




Syndicate

You are here : 3-RX.com > Home > Psychiatry / Psychology

 

Anorexia may represent an addiction

Psychiatry / PsychologyOct 03 07

Scientists from France have found that anorexia and the highly addicting club-drug ecstasy activate some of the same brain pathways, a finding that may help explain the addictive nature of anorexia and other eating disorders and lead to new treatments.

In a paper published this week, Dr. Valerie Compan of Centre National de la Recherche Scientifique, Montpellier, and colleagues report that both anorexia and ecstasy reduce the drive to eat by stimulating the same subset of receptors for the neurotransmitter serotonin. 

- Full Story - »»»    

Drop in antidepressant use seen during pregnancy

Drug News • • Pregnancy • • Psychiatry / PsychologyOct 03 07

A marked fall in antidepressant use occurs when women first learn that they are pregnant, according to a report.

“It is alarming to see that there is still a fear regarding antidepressant use during pregnancy. We knew that some women were going to discontinue using their antidepressants during pregnancy but we didn’t think it would be so prevalent and inappropriately used (amongst those who remain on it),” senior author Dr. Anick Berard told Reuters Health. 

- Full Story - »»»    

Psoriasis drug shown highly effective in trial

Drug News • • Skin CareOct 03 07

Johnson & Johnson’s experimental treatment for psoriasis proved safe and highly effective in a late-stage trial, positioning it as a potential strong rival to current medicines, the company said on Wednesday.

More than two-thirds of patients with moderate to severe forms of the inflammatory skin condition achieved at least a 75 percent reduction in symptoms after 12 weeks of treatment with the injectable medicine CNTO 1275 (ustekinumab), J&J said. 

- Full Story - »»»    

New York City’s infant mortality rate declined in 2006

Public HealthOct 03 07

New York City’s infant mortality rate – widely regarded as a barometer of a population’s general health – fell slightly in 2006, the Health Department reported today. The rate in 2006 was 5.9 infant deaths for every 1,000 births, down from 6.0 the previous year. The City has made major progress in reducing infant deaths since the early 1990s, when the rate was double what it is today, but the decline has leveled off in recent years. The Health Department also reported that in poorer sectors of the city, infant mortality rates are still double the citywide rate.

In 2006, there were 740 infant deaths (defined as deaths of infants less than a year old) out of 125,506 New York City births. The city’s infant mortality rate is still lower than the national rate, which was 6.8 per 1,000 births in 2004, the most recent year on record. The leading causes of infant death both in New York City and nationally are birth defects, premature birth, and low birth weight.

- Full Story - »»»    

Page 1 of 1 pages

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site